SCHEMBL7670728

SCHEMBL7670728

Cc1ccc(S(=O)(=O)c2nc(-c3ccc(Cl)cc3Cl)oc2N(C)C)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.65
NPC1 O15118 1/20 0.65
KMT2A Q03164 1/20 0.65
ALDH1A1 P00352 4/20 0.63
TSHR P16473 3/20 0.63
MAPT P10636 4/20 0.59
TDP1 Q9NUW8 1/20 0.57
KDM4E B2RXH2 2/20 0.56
XPO1 O14980 1/20 0.55
HTT P42858 1/20 0.55
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
THRB P10828 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665354 0.90 ALDH1A1 (0.78) MEN1NPC1KMT2AALDH1A1TSHR
SCHEMBL7668189 0.83 MEN1 (0.88) MEN1NPC1KMT2AALDH1A1TSHR
SCHEMBL7675868 0.79 POLB (0.80) KMT2AALDH1A1TSHRMAPTTDP1
SCHEMBL3017559 0.77 ALDH1A1 (1.00) MEN1NPC1KMT2AALDH1A1TSHR
SCHEMBL6823671 0.76 MEN1 (0.87) MEN1NPC1KMT2AALDH1A1TSHR
SCHEMBL7670400 0.75 MAPT (0.67) MEN1KMT2AALDH1A1TSHRMAPT
SCHEMBL7669067 0.68 MAPT (0.67) MEN1NPC1KMT2AALDH1A1TSHR
SCHEMBL7668097 0.68 MAPT (0.74) KMT2AALDH1A1TSHRMAPTKDM4E
SCHEMBL7671937 0.67 POLB (1.00) MEN1KMT2AALDH1A1TSHRMAPT
SCHEMBL7669614 0.67 MAPT (0.82) MEN1NPC1KMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6441013-B1 5-HT6 RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERCK PATENT GMBH (DE) 2002-08-27 US disclosed
EP-1140875-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GmbH (DE) 2001-10-10 EP disclosed
WO-2000037452-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GMBH (DE) 2000-06-29 WO disclosed